Deutsche Bank Ag\ Entrada Therapeutics, Inc. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
A detailed history of Deutsche Bank Ag\ transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 13,983 shares of TRDA stock, worth $185,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,983
Previous 10,227
36.73%
Holding current value
$185,414
Previous $145,000
53.79%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TRDA
# of Institutions
104Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$64.5 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$58.7 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$58.5 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$40.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$22.7 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $416M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...